UPL Ltd

Q3 FY26Fertilizers & Agrochemicals

UPL Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹569

Market cap₹47.5K Cr

P/E24.0

Updated23 Aug 2026

Read4 min read

The short version

UPL expects full-year FY '26 revenue growth of 4% to 8% and EBITDA growth of 12% to 16%. UPL maintains full-year FY '26 guidance with expectations of 4% to 8% revenue growth and 12% to 16% EBITDA growth.

From UPL Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

UPL expects full-year FY '26 revenue growth of 4% to 8% and EBITDA growth of 12% to 16%. (Page 10)
The company anticipates volume-led growth in Q4, supported by in-season demand and higher revenues from new product launches. (Page 8)
New product launches are on track to exceed a $130 million revenue target in FY '26, with strong traction in Brazil and LATAM, expected to accelerate in Q4. (Page 9)
Regional growth expected in Q4 across all markets, including Europe, North America, Latin America, Africa, and Asia Pacific. (Pages 9-11)
North America’s growth expected to be stronger in Q4 due to delayed sales from Q3 and strong herbicide demand. (Page 11)
Sustainable solutions are scaling, delivering strong growth, particularly in Europe and Asia Pacific with 11% revenue growth in Q3. (Page 7)
Market cautiousness remains due to tariff uncertainty and trade issues, but overall momentum is positive. (Pages 7, 11)

Profitability & Margins

UPL maintains full-year FY '26 guidance with expectations of 4% to 8% revenue growth and 12% to 16% EBITDA growth.
Q4 anticipated to see growth across all regions, supported by strong in-season demand and new product launches.
Contribution margins expected to expand due to improved product mix, higher capacity utilization, and lower input costs.
Management confident in delivering strong Q4 results focusing on top line, bottom line, and cash generation.
EBITDA growth is strong year-to-date, with 22% growth over 9 months and margin improvements.
Profit before tax (PBT) increased significantly by 90% Y-o-Y in Q3, supported by reduced finance costs and improved joint venture performance.
The company aims for sustainable improvement in business quality and operational efficiency.
Earnings growth driven by volume expansion, new products, cost control, and debt reduction initiatives.

See what UPL Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The document does not explicitly mention specific current or future capex or capital investment amounts.
There is a focus on strategic investments in new product launches, particularly in the crop protection segment, with a strong new product pipeline exceeding $130 million revenue target for new products this year.
Emphasis on operational excellence and manufacturing excellence contributing to cost reductions.
Advancement in sustainable solutions category with 11% revenue growth reflects strategic investment in this segment.
Advanta (seeds business) is undergoing corporate actions including IPO filing, indicating strategic investment in value unlocking and possible future capital allocation.
Management is investing selectively in SG&A towards growth and enterprise-wide transformation initiatives.
Debt repayment and deleveraging efforts indicate disciplined capital management but no direct mention of large capex outlays.
Overall, strategic focus appears to be on product innovation, market expansion, and ESG leadership rather than heavy capital expenditure.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential

1Anya Polytech &₹180 Cr

Rev 2Mar 1

2Dharmaj Crop Guard Ltd₹911 Cr

Rev 2Mar 2

3₹5.6K Cr

Rev 2Mar 3

4₹1.3K Cr

Rev 3Mar 1

5₹56.9K Cr

Rev 3Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

No explicit mention of new fundraising through debt or equity during the call.
Management emphasizes deleveraging with expected reduction in net debt-to-EBITDA ratio from 2.1x to between 1.6x-1.8x by March 2026, indicating net debt is expected to decrease rather than increase.
Upcoming debt maturities (e.g., $500 million in March 2026 and $400 million in September 2026) are planned to be met through operational cash flow, existing cash balances, and unutilized working capital lines.
IPO of Advanta is planned as an offer-for-sale, with cash proceeds going to existing shareholders (UPL and KKR) for deleveraging, not as a primary capital raise for Advanta.
Management is comfortable with cash position and options to handle capital structure as required but no mention of new debt or equity fundraising at this time.

See what UPL Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript from UPL Limited's Q3 & 9MFY26 earnings call does not explicitly mention current or expected order book or pending orders figures. However, some relevant information that implies strong demand and order momentum includes: - Strong momentum and confidence in Q4 performance, with growth expected across all regions. - January reinforced confidence due to solid order intake and customer engagement. - Record high prepay dollars in the U.S., indicating strong distributor commitments and order pipeline. - Strong in-season demand and higher revenues anticipated in Q4 from new product launches. - Supply chain readiness for a strong Q4, implying anticipated order fulfillment. - Overall cautious but positive outlook for revenue and EBITDA growth for the full financial year. No specific quantification of order book or pending orders is provided in the transcript.

UPL Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹18.3K Cr, net profit ₹1.3K Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What UPL Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Indogulf Cropsciences Ltd (Q3 FY26)
The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…
Rallis India Ltd (Q3 FY26)
Domestic B2C business growing steadily with 13% growth in Q3; volume expansion despite some price softness. Key concall takeaways from Rallis India's Q3 FY26…
Sharda Cropchem Ltd (Q3 FY26)
Capex planned in the range of INR 450-500 crores to support growth and registration activities. Key concall takeaways from Sharda Cropchem Ltd's Q3 FY26…
Krishana Phoschem Ltd (Q3 FY26)
It is noted that manufacturing is operating at almost 100% capacity and the company is importing to meet excess demand. Key concall takeaways from Krishana…

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs P I Industries Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were UPL Ltd Q3 FY26 results?

What is UPL Ltd share price analysis?

UPL Ltd currently shows a neutral. The stock trades at a P/E of 24.0 with a market cap of ₹47,512 Cr. Investors should review the full earnings analysis for detailed insights.

Is UPL Ltd planning capital expenditure?

The document does not explicitly mention specific current or future capex or capital investment amounts.

Keep UPL Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.